Phase 1 Study of PK and Safety of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Subjects With Various Degrees Of Renal Function
Clinical trial NCT04178577 · COMPLETED
Trial details
- NCT number
- NCT04178577
- Sponsor
- Spero Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-06
- Primary completion
- 2020-09-06
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.